Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Современные достижения в доставке нуклеиновых кислот с использованием экзосом для терапии рака
2022-06-14
SCID: 54.1/ar8y6g82
Discuss with AI
cancer therapyexosome-mediated nucleic acid deliveryextracellular vesiclesgene therapynucleic acid drugs
Figures from the paper
Abstract (AI)
Cancer is a leading public health problem worldwide. Its treatment remains a daunting challenge, although significant progress has been made in existing treatments in recent years. A large concern is the poor therapeutic effect due to lack of specificity and low bioavailability. Gene therapy has recently emerged as a powerful tool for cancer therapy. However, delivery methods limit its therapeutic effects. Exosomes, a subset of extracellular vesicles secreted by most cells, have the characteristics of good biocompatibility, low toxicity and immunogenicity, and great designability. In the past decades, as therapeutic carriers and diagnostic markers, they have caught extensive attention. This review introduced the characteristics of exosomes, and focused on their applications as delivery carriers in DNA, messenger RNA (mRNA), microRNA (miRNA), small interfering RNA (siRNA), circular RNA (circRNA) and other nucleic acids. Meanwhile, their application in cancer therapy and exosome-based clinical trials were presented and discussed. Through systematic summarization and analysis, the recent advances and current challenges of exosome-mediated nucleic acid delivery for cancer therapy are introduced, which will provide a theoretical basis for the development of nucleic acid drugs.
Key Findings
1
Current challenges in exosome-mediated nucleic acid delivery are identified, providing a basis for developing nucleic acid therapeutics.
2
Exosomes may address poor specificity and low bioavailability that limit conventional cancer treatments and gene therapy delivery.
3
Exosomes offer biocompatible, low-toxicity, low-immunogenicity, and designable platforms for nucleic acid delivery in cancer therapy.
4
The review examines exosome-mediated delivery of DNA, mRNA, miRNA, siRNA, circular RNA, and other nucleic acids.
5
The review summarizes applications of exosome-based nucleic acid delivery in cancer therapy and discusses related clinical trials.
Research Object
Exosome-mediated nucleic acid delivery systems for cancer therapy
Research Subject
The delivery-carrier properties, therapeutic applications, and current challenges of exosomes for transporting DNA, mRNA, miRNA, siRNA, circRNA, and other nucleic acids in cancer therapy
Publication Details
Publication Date
2022-06-14
Journal
Publisher
ISSN
Cited by
305
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest